Sulforaphane in Treating Patients With Recurrent Prostate Cancer

Clinical Trial ID NCT01228084

Rank	Title	Journal	Year	PubWeight™‹?›
1	Management of biochemically recurrent prostate cancer after local therapy: evolving standards of care and new directions.	Clin Adv Hematol Oncol	2013	1.22
2	Dual roles of NRF2 in tumor prevention and progression: possible implications in cancer treatment.	Free Radic Biol Med	2014	0.98
3	A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer.	Invest New Drugs	2014	0.92
4	Dietary Sulforaphane in Cancer Chemoprevention: The Role of Epigenetic Regulation and HDAC Inhibition.	Antioxid Redox Signal	2014	0.83
5	Pilot study evaluating broccoli sprouts in advanced pancreatic cancer (POUDER trial) - study protocol for a randomized controlled trial.	Trials	2014	0.82
6	Frugal chemoprevention: targeting Nrf2 with foods rich in sulforaphane.	Semin Oncol	2015	0.80
7	Sulforaphane induces apoptosis in rhabdomyosarcoma and restores TRAIL-sensitivity in the aggressive alveolar subtype leading to tumor elimination in mice.	Cancer Biol Ther	2014	0.79
8	Effects of the antioxidant sulforaphane on hyperlocomotion and prepulse inhibition deficits in mice after phencyclidine administration.	Clin Psychopharmacol Neurosci	2012	0.79
9	Epigenetic modulators as therapeutic targets in prostate cancer.	Clin Epigenetics	2016	0.76